[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Collegium Announces $50 Million Accelerated Share Repurchase Program

STOUGHTON, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and...

COLL : 28.15 (+9.53%)
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call

5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call

COLL : 28.15 (+9.53%)
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance

COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance

COLL : 28.15 (+9.53%)
Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops

Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops

COLL : 28.15 (+9.53%)
Collegium Pharmaceutical: Q2 Earnings Snapshot

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL : 28.15 (+9.53%)
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

– Completed Acquisition of AZSTARYS ® , Strengthening ADHD Portfolio and Extending Long-Term Revenue Outlook – – Generated Quarterly Net Revenues of $199.9 Million, Up 6% Year-over-Year...

COLL : 28.15 (+9.53%)
Collegium's Pain Portfolio Faces Its First Test Without Guidance

Barchart Research What to Expect from COLL Earnings COLL Generated August 5, 2026 Current Price $35.74 EPS Estimate $$1.48 Consensus Rating Moderate Buy Average Move 4.85% Collegium's Pain Portfolio Faces...

COLL : 28.15 (+9.53%)
Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

COLL : 28.15 (+9.53%)
1 Cash-Producing Stock Worth Investigating and 2 We Ignore

1 Cash-Producing Stock Worth Investigating and 2 We Ignore

COLL : 28.15 (+9.53%)
GMED : 85.94 (+0.32%)
WOOF : 2.86 (+4.76%)
Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks

Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks

COLL : 28.15 (+9.53%)

Barchart Exclusives

H&R Block Posted Strong Earnings and Boosted Its Dividend by Nearly 10%. What This Means for HRB Stock.
H&R Block beat fiscal fourth-quarter estimates, raised its fiscal 2027 outlook, and increased its quarterly dividend by nearly 10% to $0.46 per share, sending the stock up about 16%. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.